Bailard Inc. Takes $239,000 Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Bailard Inc. acquired a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 402 shares of the biotechnology company’s stock, valued at approximately $239,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in AXON. Geode Capital Management LLC increased its stake in shares of Axon Enterprise by 2.0% in the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after purchasing an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP boosted its holdings in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after buying an additional 127,769 shares during the period. Champlain Investment Partners LLC grew its stake in Axon Enterprise by 13.9% in the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after buying an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after acquiring an additional 9,090 shares during the period. Finally, Groupama Asset Managment purchased a new stake in shares of Axon Enterprise during the third quarter worth $200,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Up 1.3 %

AXON opened at $534.96 on Thursday. The business’s fifty day simple moving average is $605.52 and its 200 day simple moving average is $527.52. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $40.79 billion, a PE ratio of 138.23, a P/E/G ratio of 5.17 and a beta of 1.12.

Insider Transactions at Axon Enterprise

In other news, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the sale, the director now directly owns 24,259 shares in the company, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, President Joshua Isner sold 1,291 shares of the company’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the completion of the sale, the president now directly owns 181,892 shares of the company’s stock, valued at $116,852,877.56. This trade represents a 0.70 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 5,146 shares of company stock worth $3,262,847. 6.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on AXON shares. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $587.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.